These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9243784)

  • 41. Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDs.
    Watson DJ; Harper SE; Zhao PL; Bolognese JA; Simon TJ
    MedGenMed; 2001 Nov; 3(4):6. PubMed ID: 11965201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction of systemic exposure and side effects by intra-articular injection of anti-inflammatory agents for osteoarthritis: what is the safer strategy?
    Xie Z; Wang L; Chen J; Zheng Z; Srinual S; Guo A; Sun R; Hu M
    J Drug Target; 2023 Jul; 31(6):596-611. PubMed ID: 37249274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs.
    Lascelles BD; Gaynor JS; Smith ES; Roe SC; Marcellin-Little DJ; Davidson G; Boland E; Carr J
    J Vet Intern Med; 2008; 22(1):53-9. PubMed ID: 18289289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic therapy for osteoarthritis.
    Goldberg SH; Von Feldt JM; Lonner JH
    Am J Orthop (Belle Mead NJ); 2002 Dec; 31(12):673-80. PubMed ID: 12498526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee.
    Watson MC; Brookes ST; Kirwan JR; Faulkner A
    Cochrane Database Syst Rev; 2000; (2):CD000142. PubMed ID: 10796306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Actions and toxic effects of the nonsteroidal anti-inflammatory drugs.
    Simon LS
    Curr Opin Rheumatol; 1994 May; 6(3):238-51. PubMed ID: 8060759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review.
    Lees P; Pelligand L; Elliott J; Toutain PL; Michels G; Stegemann M
    J Vet Pharmacol Ther; 2015 Feb; 38(1):1-14. PubMed ID: 25413929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GP and patient perspectives on treatment with non-steroidal anti-inflammatory drugs for the treatment of pain in osteoarthritis.
    Crichton B; Green M
    Curr Med Res Opin; 2002; 18(2):92-6. PubMed ID: 12017216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
    Moore A; Phillips C; Hunsche E; Pellissier J; Crespi S
    Pharmacoeconomics; 2004; 22(10):643-60. PubMed ID: 15244490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
    Mastbergen SC; Bijlsma JW; Lafeber FP
    Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
    Wepner U
    MMW Fortschr Med; 2002 Mar; 144(13):4-8. PubMed ID: 12001589
    [No Abstract]   [Full Text] [Related]  

  • 52. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
    Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
    Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives.
    Henrotin Y; Sanchez C; Balligand M
    Vet J; 2005 Jul; 170(1):113-23. PubMed ID: 15993795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of enflicoxib for treatment of canine osteoarthritis: A 6-week randomised, controlled, blind, multicentre clinical trial.
    Salichs M; Badiella L; Sarasola P; Homedes J
    Vet Rec; 2022 Sep; 191(6):e949. PubMed ID: 34590318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Canine Orthopedic Index. Step 3: Responsiveness testing.
    Brown DC
    Vet Surg; 2014 Mar; 43(3):247-54. PubMed ID: 24617818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo.
    Brandt KD
    Am J Med; 1987 Nov; 83(5A):29-34. PubMed ID: 3120584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of force plate gait analysis and owner assessment of pain using the Canine Brief Pain Inventory in dogs with osteoarthritis.
    Brown DC; Boston RC; Farrar JT
    J Vet Intern Med; 2013; 27(1):22-30. PubMed ID: 23311715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guidelines for safe and effective use of NSAIDs in dogs.
    Lascelles BD; McFarland JM; Swann H
    Vet Ther; 2005; 6(3):237-51. PubMed ID: 16299670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
    Lee MC; Lee S; Suh DC; Kim J; Kong SX;
    Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.